Teleflex (NYSE:TFX) Trading Down 7% – Here’s What Happened

Teleflex Incorporated (NYSE:TFX)’s share price fell 7% on Thursday . The stock traded as low as $125.18 and last traded at $123.9770. 173,065 shares were traded during trading, a decline of 82% from the average session volume of 963,433 shares. The stock had previously closed at $133.30.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Needham & Company LLC upped their target price on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Bank of America upgraded Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target for the company in a research report on Monday, April 13th. Raymond James Financial upgraded Teleflex from a “market perform” rating to an “outperform” rating and set a $128.00 price objective for the company in a research report on Friday, March 27th. Wells Fargo & Company lifted their target price on Teleflex from $116.00 to $130.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Finally, Zacks Research upgraded Teleflex from a “strong sell” rating to a “hold” rating in a research note on Tuesday. Three investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $138.50.

Teleflex Stock Performance

The company has a debt-to-equity ratio of 0.81, a quick ratio of 2.01 and a current ratio of 2.54. The company has a market capitalization of $5.53 billion, a price-to-earnings ratio of -6.09, a P/E/G ratio of 0.97 and a beta of 0.84. The stock’s 50-day moving average price is $118.49 and its 200-day moving average price is $116.73.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, February 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.73 by ($1.80). The company had revenue of $569.00 million for the quarter, compared to analyst estimates of $912.57 million. Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The company’s revenue for the quarter was down 28.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.89 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts expect that Teleflex Incorporated will post 6.77 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Friday, March 6th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend was Friday, March 6th. Teleflex’s dividend payout ratio is -6.62%.

Hedge Funds Weigh In On Teleflex

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. AQR Capital Management LLC lifted its position in shares of Teleflex by 478.1% during the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after purchasing an additional 1,956,811 shares during the last quarter. Abrams Bison Investments LLC acquired a new stake in Teleflex during the third quarter worth about $112,317,000. Norges Bank acquired a new stake in shares of Teleflex in the fourth quarter valued at approximately $66,076,000. Thrivent Financial for Lutherans increased its stake in shares of Teleflex by 1,161.0% in the third quarter. Thrivent Financial for Lutherans now owns 550,449 shares of the medical technology company’s stock valued at $67,353,000 after purchasing an additional 506,796 shares during the period. Finally, Wolf Hill Capital Management LP acquired a new stake in shares of Teleflex in the fourth quarter valued at approximately $47,405,000. 95.62% of the stock is owned by hedge funds and other institutional investors.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.